Related Stories

TMA Develops New AI Education - 03/10/2024

Responding to significant interest from members after a 2023 standing-room-only TexMed event, the Texas Medical Association has developed a free webinar for members to learn how to integrate augmented or artificial intelligence technology, including ChatGPT, into patient care.

Find Other CME - 02/29/2024

Check out other CME offerings from around the state.

May Owen, MD, Outreach Program Funds Women Physician Programs, Activities - 02/26/2024

To partner with small and mid-sized county medical societies to provide women physicians with programming and activities at the local level, the Texas Medical Association’s Women Physicians Section has established the May Owen, MD, Outreach Program.

TexMed 2024 CME Submissions Are Open - 01/11/2024

Have an educational topic in mind to be considered for TexMed 2024, taking place at the Omni Dallas, May 2-4, 2024?

Physicians’ DEA Registration Now Requires Training on Substance Use Disorder - 01/03/2024

Physicians who must register or renew their registration for a Drug Enforcement Administration license will face a new requirement as of June 27: To register, they will have attest to taking a one-time, eight-hour training on how to treat patients with opioid or other substance use disorders.

Feds Extend Telemedicine Prescribing Flexibilities Through 2024 - 11/10/2023

With permanent telehealth prescribing policies still under consideration, the U.S. Drug Enforcement Administration (DEA) again has extended temporary pandemic-era telehealth flexibilities to allow physicians to virtually prescribe certain controlled medications, now through Dec. 31, 2024.

CDC Grant Funds Drug Overdose Data Collection in Texas - 10/30/2023

A nearly $4 million grant from the Centers for Disease Control and Prevention could give Texas physicians new tools to handle national opioid and mental health crises, which have made it difficult to identify patients at risk for substance use disorders.

Help Promote National Drug Prescription Take Back Day on Oct. 28 - 10/19/2023

Prescription Drug Take Back Day, which allows people to dispose of prescription drugs safely and anonymously, is scheduled for Oct. 26 at locations throughout the state.

Physicians Warn: New Drug Overdose Threat Contains Veterinary Tranquilizer Xylazine - 09/18/2023

Xylazine, a tranquilizer used in veterinary medicine, is appearing in illicit street drugs with fentanyl, compounding the dangers of the opioid overdose epidemic. Xylazine, also called “tranq” according to the U.S. Drug Enforcement Administration, is used to tranquilize animals. It is not approved for human use and has killed people who have taken the drug.

Physicians Alarmed by Sharp Spike in Accidental Overdose Deaths Fueled by Illegal Drugs - 09/18/2023

A surge in accidental opioid overdose deaths in Texas is showing no signs of slowing down, and Texas physicians warn the rise in illegally produced drugs laced with fentanyl are to blame. They also say increasing the availability of life-saving, overdose-reversing drugs like naloxone, as well as addiction treatment programs, can help.

Physicians Urge Texans to Safely Return Unused Prescription Medication - 09/18/2023

Texas physicians recommend people with unused or expired prescription drugs at home dispose of them safely this weekend, so they are not accidently consumed. The U.S. Drug Enforcement Administration is organizing its biannual prescription drug Take Back Day on Saturday, Oct. 29. Prescription drugs can be returned anonymously at pop up locations across the state.

New CME! Talk to Parents About Vaccine-Preventable Diseases - 09/06/2023

Talking to parents about vaccines can be challenging, especially with the anti-vaccine movement, and the COVID-19 pandemic has caused a decline in childhood vaccinations across the country. That’s why the Texas Medical Association has created a CME course to better prepare you for these conversations.

Business of Medicine Conference Offers More – And More Practical – Educational Programming - 08/31/2023

With an eye toward equipping physicians to navigate the modern medical practice landscape, the Texas Medical Association’s inaugural Business of Medicine conference in October offers more than triple the amount of educational content compared with last year’s counterpart, Fall Conference.

Opioids: Resources for Prescribing and Addiction Treatment - 07/20/2023

Get access to information about medication-assisted treatment for opioid use disorder. Online resources for prescribing opioids appropriately also are available.

Ask TMA Experts About Grassroots Virtual Advocacy - 07/17/2023

Ready to take the plunge into grassroots advocacy at the legislature but still not confident about what to do and how to do it? The Texas Medical Association’s Feb. 25 Ask the Expert session is your opportunity to ask questions about tactics, tools, messaging, and more, and how it all works in a virtual environment.

Continuing Medical Education Programs - 07/13/2023

The Physician Health and Wellness (PHW) Committee offers several ongoing courses on a wide range of topics to educate physicians, TMA Alliance members, hospital administrators, and others. PHW activities encourage physicians to promote and maintain their health and wellness, which fosters healthy lifestyles in patients.

Welcome MAT: Physicians Debunk Skepticism of Medication-Assisted Treatment - 06/05/2023

Many physicians have concerns about medication-assisted treatment (MAT) for substance use disorders. But a better understanding of MAT – combined with recent changes in federal law about prescribing these medications and required physician education on the subject – will allow a much broader group of doctors to help tackle the opioid crisis.

DEA Extends Telemedicine Flexibilities for Prescription of Controlled Medications - 05/12/2023

To avoid lapses in patient care now that the COVID-19 public health emergency has ended, the Drug Enforcement Administration and the Substance Abuse and Mental Health Services Administration issued a temporary extension of telemedicine flexibilities for the prescribing of controlled medications originally adopted in March 2020.

Medication-Assisted Treatment for Opioids, Alcohol, Tobacco: What You Should Know - 04/19/2023

Concern about opioids – especially the growing threat of overdose posed by illicit fentanyl – has created heightened awareness about treatment options for people with substance use disorders. One of the oldest and most effective is medication-assisted treatment.

UPDATE: Feds Declare Xylazine an Emerging National Threat in Opioid Crisis - 04/14/2023

Physicians’ ability to diagnose and treat opioid-related overdoses may be complicated by the discovery of the animal tranquilizer xylazine mixed in illicit fentanyl-laced drugs, the Texas Department of State Health Services warned in a recent health advisory.

TexMed 2023 Presents Can’t-Miss CME – With New and Improved Schedule - 04/06/2023

Physicians at this year’s TexMed will have a rich selection of CME to attend, aided by improved scheduling.

Opioid Crisis: Illegally Manufactured Fentanyl Facts and Resources - 04/06/2023

Use these resources to get the facts and learn more about how illegally manufactured fentanyl is impacting public health.

Abbott Signals Support for Opioid Crisis Interventions: Federal Efforts Also Are Underway - 04/05/2023

Texas Gov. Greg Abbott in February listed the fentanyl crisis as one of seven “emergency” items this session, clearing a path toward passage of Texas Medical Association-backed legislation that aims to curb opioid-related deaths.

FDA Approves Naloxone Nasal Spray for Over-the-Counter Sale - 04/03/2023

The Food and Drug Administration has approved over-the-counter sales of the opioid-reversing medication Narcan nasal spray – a move Texas physicians have long championed.

DEA Permanently Lists Opioid Brorphine as a Schedule I Controlled Substance - 03/24/2023

The Drug Enforcement Administration recently listed the synthetic opioid brorphine as a Schedule I controlled substance, putting in in the same league as other potentially dangerous drugs that have no accepted medical use, like heroin and LSD.